INDSWFTLAB.NS Ind-Swift Laboratories Limited

P/E 46.58471
Forward P/E --
Price/Sales 3.057451
Beta 0.579
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Ind-Swift Laboratories is trading 11.81% up today — catalyst remains unclear

Ind-Swift Laboratories is trading at INR 362.68, up 11.81%, with no clear company-specific announcement directly explaining the August 26, 2026 move. - Recent...

🟢 Ind-Swift Laboratories is trading 5.8% up today

Ind-Swift Laboratories is trading at INR 343.28, up 5.83%, with no clear company-specific announcement explaining the August 26, 2026 move. - Q1 FY27 PAT rose...

🔴 Ind-Swift Laboratories is trading 5.38% down today after an exceptional rally

Ind-Swift Laboratories is trading 5.38% down at INR 328.22, following an exceptional rally from INR 237.24 on August 10 to INR 313.02 on August 17. No clear...

Ind-Swift Labs Triples Its Operating Profit and Stock Surges 45% in a Week — But Can a Small Pharma Sustain This Momentum

Ind-Swift Labs Triples Its Operating Profit and Stock Surges 45% in a Week — But Can a Small Pharma Sustain This Momentum

Shares of Ind-Swift Laboratories rocketed as much as 13.3% on August 18, landing at INR 344.58, capping a stunning 45% rally from the INR 237.24 close just...

🟢 Ind-Swift Laboratories is trading 10.08% up today after strong Q1 FY27 results

Ind-Swift Laboratories is trading 10.08% up at INR 344.58, as investors continued responding to strong Q1 FY27 results and the August 17, 2026 earnings-call...

🟢 Ind-Swift Laboratories is trading 5.61% up today after strong Q1 FY27 results

Ind-Swift Laboratories is trading 5.61% up now at INR 330.59, as investors continue responding to strong Q1 FY27 results and the August 17 earnings-call...

🟢 Ind-Swift Laboratories is trading 11.75% up today after 201.05% profit jump

Ind-Swift Laboratories is trading at ₹318.14, up 11.75%, after standalone net profit jumped 201.05% year-on-year to ₹24.44 crore in the June quarter. - EBITDA...

Ind-Swift Labs Surges 20% on Promoter Warrant Deal — Is This Expansion Bet Worth the Dilution Risk?

Ind-Swift Labs Surges 20% on Promoter Warrant Deal — Is This Expansion Bet Worth the Dilution Risk?

Shares of Ind-Swift Laboratories vaulted 20% to ₹274.10 on August 11, extending a sharp rally after shareholders greenlit a ₹137.20 crore warrant issue to...

🟢 Ind-Swift Laboratories surges 15.54% on strong Q1 earnings and approval of ₹137.20 crore warrants

Ind-Swift Laboratories is trading at INR 274.10 (+15.54%) today, driven by two key company-specific catalysts. The company reported significantly improved...

🟢 Ind-Swift Laboratories is trading 5% up today after shareholder approval of ₹137.20 crore warrants

Ind-Swift Laboratories is trading at INR 240.00, up +5.07%, after shareholder approval of ₹137.20 crore of fully convertible warrants to promoter entities on...

🔴 Ind-Swift Laboratories is trading 5% down today amid potential profit-taking after recent gains

Ind-Swift Laboratories is trading at INR 224.49, down 5% today, as the stock gives back a portion of its recent gains in a move likely driven by...

🟢 Ind-Swift Laboratories is trading 5% up today following a Q4 results-driven re-rating and sector tailwinds

Ind-Swift Laboratories is trading 5% up at $238.99 following a strong re-rating move triggered by its recent quarterly performance. • The primary catalyst for...

Ind-Swift Laboratories approves ₹137.2 crore promoter fundraise, strengthening capital

Ind-Swift Laboratories approves ₹137.2 crore promoter fundraise, strengthening capital

Ind-Swift Laboratories' Board of Directors approved a ₹137.2 crore ($16.5 million) fundraise on July 10, 2026. The company will issue up to 7,000,000 fully...

🟢 Ind-Swift Laboratories Limited is trading 5.02% up in pre-market

INDSWFTLAB.NS is trading at $247.40, up 5.02% in pre-market.

🟢 Ind-Swift Laboratories is trading 5.1% up today on board meeting to consider fund-raising

Ind-Swift Laboratories is trading 5.1% up at INR 236.94 after the company announced a board meeting scheduled for July 10, 2026, to consider raising funds via...